242 related articles for article (PubMed ID: 32094357)
21. Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway.
Li D; Li P; Guo Z; Wang H; Pan W
Int J Mol Med; 2017 Mar; 39(3):757-763. PubMed ID: 28112362
[TBL] [Abstract][Full Text] [Related]
22. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
Phillips JD; Zhang H; Wei T; Richter GT
JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
[TBL] [Abstract][Full Text] [Related]
23. Curcumin induces apoptosis and inhibits proliferation in infantile hemangioma endothelial cells via downregulation of MCL-1 and HIF-1α.
Lou S; Wang Y; Yu Z; Guan K; Kan Q
Medicine (Baltimore); 2018 Feb; 97(7):e9562. PubMed ID: 29443732
[TBL] [Abstract][Full Text] [Related]
24. Effects of oral propranolol on a juxtapapillary capillary hemangioma: a single-subject pilot study.
Tanabe H; Sahashi K; Kitano T; Tomita Y; Saito AM; Hirose H
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):380-3. PubMed ID: 25856826
[TBL] [Abstract][Full Text] [Related]
25. Recurrence of infantile hemangioma after termination of propranolol treatment.
Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
[TBL] [Abstract][Full Text] [Related]
26. Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta.
Lee JC; Modiri O; England RW; Shawber CJ; Wu JK
Plast Reconstr Surg; 2021 Apr; 147(4):875-885. PubMed ID: 33776033
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of infantile hemangiomas treated with propranolol.
Bagazgoitia L; Hernández-Martín Á; Torrelo A
Pediatr Dermatol; 2011; 28(6):658-662. PubMed ID: 22082463
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-203 inhibits invasion and induces apoptosis of laryngeal cancer cells via targeting LASP1.
Tan J; Jing YY; Han L; Zheng HW; Shen JX; Zhang LH; Yu LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6350-6357. PubMed ID: 30338803
[TBL] [Abstract][Full Text] [Related]
30. Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study.
Hermans DJ; Zweegers J; Evers AW; Van Der Vleuten CJ
Eur J Dermatol; 2013; 23(6):857-63. PubMed ID: 24185746
[TBL] [Abstract][Full Text] [Related]
31. Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas?
Yarbrough KB; Tollefson MM; Krol AL; Leitenberger SL; Mann JA; MacArthur CJ
Pediatr Dermatol; 2016 Nov; 33(6):615-620. PubMed ID: 27599450
[TBL] [Abstract][Full Text] [Related]
32. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas.
Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S
Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512
[TBL] [Abstract][Full Text] [Related]
33. Infantile Hemangiomas.
Hasbani DJ; Hamie L
Dermatol Clin; 2022 Oct; 40(4):383-392. PubMed ID: 36243426
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
[TBL] [Abstract][Full Text] [Related]
35. Update on infantile hemangiomas.
Lee KC; Bercovitch L
Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
[TBL] [Abstract][Full Text] [Related]
36. Failure of intralesional propranolol in infantile hemangiomas.
Torres-Pradilla M; Baselga E
Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
[TBL] [Abstract][Full Text] [Related]
37. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas.
Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R
Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620
[TBL] [Abstract][Full Text] [Related]
38. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers.
Martin K; Blei F; Chamlin SL; Chiu YE; Frieden IJ; Frommelt PC; Garzon MC; Kwon EK; MacLellan-Tobert S; Mancini AJ; Seefeldt M; Sidbury R; Siegel DH; Drolet BA; Boucek RJ
Pediatr Dermatol; 2013; 30(1):155-9. PubMed ID: 23316721
[TBL] [Abstract][Full Text] [Related]
39. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
40. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]